New blood thinner in the pipeline…..

A new blood-thinning medication called semuloparin reduces the risk of blood clots in people undergoing certain cancer treatments, new research shows.

When people with cancer are treated with chemotherapy, they have an increased risk of developing blood clots (venous thromboembolism). These clots can be dangerous, and have the potential to cause heart attacks or strokes.

Thromboembolus, partially organized

Thromboembolus, partially organized (Photo credit: Pulmonary Pathology)

This new drug reduced the risk of blood clots by 64 percent, according to the study, which was funded by Sanofi, the drug’s manufacturer. Sanofi was also responsible for the analysis of the study’s results.

An example of a heart attack, which can occur ...

Semuloparin, which is not currently approved by the U.S. Food and Drug Administration, didn’t appear to increase the risk of excessive bleeding, which can be a side effect of blood thinners.

Advertisements

4 thoughts on “New blood thinner in the pipeline…..

  1. what is the api?is it aspirin…

  2. nishat sultana sudha

    i hrd that its in hypothesis stage…….

What is your opinion?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s